CardioGenesis concurs with FDA on heart laser trial
This article was originally published in Clinica
Executive Summary
CardioGenesis says that an agreement has been reached with the US FDA as to what steps are needed for the initiation of yet another clinical trial of its controversial percutaneous laser treatment for angina.